This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Aug. 22, 2012

Home   About   Join Us   Annual Conference   The Voice   Career Center   Resources   Education Plus  

 

Scientists solve key piece of prostate cancer puzzle
Medical Xpress    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Cancer Research U.K. scientists have revealed a completely new route by which male androgen hormones fuel the growth of prostate cancer, raising the prospect that existing drugs could be used to treat the disease. Prostate cancers are often treated with hormone therapies that target the androgen receptor – a large protein that switches on signals telling the cell to divide, and which can become overactive in prostate cancer cells. More



A new role for ASCT in cytotechnology education and program accreditation
American Society for Cytotechnology    Share    Share on FacebookTwitterShare on LinkedinE-mail article
On July 1, the Cytotechnology Programs Review Committee (CPRC) officially welcomed new sponsors to its committee — the American Society for Cytotechnology (ASCT), the American Society for Clinical Pathology (ASCP) and the College of American Pathology (CAP). The CPRC is the Committee on Accreditation (CoA) for cytotechnology education of the Commission on Accreditation of Allied Health Education Programs (CAAHEP). CAAHEP is the sole accreditation agency of cytotechnology training programs. Each CAAHEP CoA has a "sponsoring organization" that establishes or supports one or more CoAs and supports the CAAHEP accreditation system. Sponsors are usually professional societies or agencies with a stake in the graduates of CAAHEP training programs. Multiple sponsors for a CoA ensure wider representation and broader perspective concerning professional training obtained in CAAHEP-accredited programs. Sponsor organizations for a CoA must be recommended by the CoA and approved by the full commission of CAAHEP. For more information see the detailed article in the September issue of the Voice, the ASCT electronic newsletter.

UPCOMING EVENTS





Event       Location     Dates Notes

California Association of Cytotechnologists
Annual Seminar/Workshop
      Crowne Plaza,
      Irvine, Calif.
   Sept. 15 For more information contact Matt Riding at president@cacstate.org

Pathology Update 2012
“New Roles for Pathologists in the Era of Health Care Reform”
      University of
      Vermont/Fletcher
      Allen Health Care,
      Burlington, Vt.
   Sept. 22 For more information, contact Lisa Kapoor at lisa.kapoor@vtmednet.org

SOP: An Important Form of Laboratory Communication       Your PC    Sept. 25
   2 p.m. EST
Debora A. Smith, CT (ASCP)
Cytology Supervisor, The Methodist Hospital, Houston, Texas
More details | Register

St. Louis Society of Cytology Conference       Norwood Hills
      Country Club,
      St. Louis, Mo.
   
   Sept. 29
   
More information

Wisconsin Society of Cytology Conference       Country Springs
      Hotel
      Pewaukee, Wis.
   
   Oct. 13
   
More information

The ASCT 2012-2013 membership year has started! Renew your membership Here.



INDUSTRY NEWS


Study: Can daily aspirin help ward off cancer?
Reuters via Yahoo News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Taking aspirin daily may help protect against cancer but the effect seems weaker than previously thought, according to a U.S. study that included a decade's worth of data from more than 100,000 people. "News about the cancer potential of aspirin use has been really encouraging lately," said Michael Thun of the American Cancer Society, who worked on the study that appeared in the Journal of the National Cancer Institute. More

Combination peptide therapies might offer more effective, less toxic cancer treatment
Medical Xpress    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Two studies suggest that two peptide agents used either together or individually with a low-dose of a standard chemotherapy drug might offer more effective cancer therapy than current standard single-drug treatments. The studies used animal models of breast cancer to show that the peptide combinations dramatically delay tumor onset and progression by both inhibiting tumor growth and blocking the formation of new tumor blood vessels, say the researchers at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute who conducted the study. More

Should young men be vaccinated against human papillomavirus?
Medical News Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A new study published in Viral Immunology has sparked a debate on whether the human papillomavirus vaccination should be given to men. The review – available at www.liebertpub.com – was conducted by Gorren Low and colleagues from the University of Southern California and David Geffen School of Medicine, Los Angeles, and Georgetown University School of Medicine, Washington, D.C. The researchers assessed how cost effective it is to expand routine HPV vaccination to include young males as well as the potential for reducing illness caused by HPV infection. More

New discoveries in skin cancer: Protein inhibits formation of metastases
Medical Xpress    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The danger of melanomas lies in the fact that they encourage the formation of new lymph vessels (lymphangiogenesis) at a very early stage and can therefore produce metastases very early on. It is therefore crucial to find proteins that inhibit the process of lymphangiogenesis. In a study carried out by Heide Niederleithner from the University Department of Dermatology at the MedUni Vienna, it has now been demonstrated that Wnt1 is a protein capable of inhibiting lymphangiogenesis and the formation of metastases in cases of malignant melanoma. More

MORE NEWS


Material discovered in blood cells that may affect malaria parasites
Red Orbit    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers at Duke University Medical Center may finally have discovered why people with sickle cell disease get milder cases of malaria than individuals who have normal red blood cells. In a finding that has eluded scientists for years, Duke researchers discovered that genetic material in red blood cells may help alter parasite activity via a novel mechanism that alters parasite gene regulation. More

Far more could be done to stop the deadly bacteria C. diff
USA Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
VideoBriefJust days after doctors successfully removed a tumor from Bailey Quishenberry's brain, the 14-year-old was spiraling downhill, delirious and writhing in pain from an entirely new menace. Her abdomen swollen 10 times its normal size and her fever skyrocketing, Bailey began wishing she could die, just to escape the agony. Bailey had contracted a potentially fatal infection called Clostridium difficile, or C. diff, that ravages the intestines. More

Internal microscopic diagnostic devices — clinicians need more training
Medical News Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
To diagnose illness in areas of the body that are hard-to-reach, clinicians increasingly use tiny space-age probes, which can see inside single living cells. A new study published in the journal Digestive Diseases and Sciences reveals that specialists who are beginning to use these devices may be interpreting what they see in different ways. More

Chemical in antibacterial soap weakens muscle function
TIME    Share    Share on FacebookTwitterShare on LinkedinE-mail article
It turns out antibacterial soaps aren't so "clean" after all. A common chemical in antibacterial products, triclosan – which can be found in soaps, toothpastes and mouthwashes – was found to impair muscle function in lab and animal tests. Originally, the chemical, developed in the 1960s, was used in hospitals to prevent bacterial infections. More

Hepatitis C outbreak could boost regulation bill
The Associated Press via The Boston Globe    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The case of a traveling medical technologist suspected of infecting dozens of patients with Hepatitis C could give momentum to federal legislation requiring medical imaging and radiation therapy workers to meet standards so that hospitals can receive Medicare reimbursements. David Kwiatkowski is accused of stealing drugs and contaminating syringes used on patients at Exeter Hospital in New Hampshire. He previously worked at 18 hospitals in seven other states, moving from hospital to hospital despite having been fired twice over allegations of drug use and theft. More

Why whooping cough is back
Fox News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The number of whooping cough cases in the U.S. this year is on track to be the highest in 50 years, although one researcher says the main reason behind the disease's apparent resurgence is a heightened awareness of it. Besides improved reporting of cases of whooping cough (which is also called pertussis), factors in the disease's resurgence include the fact that vaccines don't completely protect against it, and that the current vaccine provides even less protection than previous ones did, according to Dr. James Cherry, a professor of pediatric infectious diseases at the David Geffen School of Medicine, UCLA. More

Lack of vitamin D can be root of many health issues
WWL-TV    Share    Share on FacebookTwitterShare on LinkedinE-mail article
VideoBriefDecades of research and thousands of studies find it's something not in your diet that may be making you fat and putting you at a higher risk for cancers. More than three-quarters of Americans are known to be deficient in this supplement. More

Alzheimer's blood test — scientists closing in
Medical News Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Scientists are a step closer to developing a blood test for Alzheimer's disease following the publication online in Neurology of a new study that found four biomarkers showed consistent results across three independent groups of patients. Current methods for diagnosing Alzheimer's are based mainly on clinical symptoms that often have to be confirmed with expensive PET scans, or by testing for beta-amyloid protein in samples of cerebrospinal fluid with a procedure that can be painful and distressing. More

Blood type may affect heart disease risk
Fox News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
People with type AB blood may have a higher risk of heart disease compared with those whose blood type is O, according to a new study. Researchers reviewed two studies that tracked nearly 90,000 people for more than 20 years and found that coronary heart disease risk varied with participants' blood types. More


 

ASCT Viewpoint
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Bob Kowalski, Content Editor, 469.420.2650   
Contribute news

This edition of ASCT Viewpoint was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Aug. 8, 2012
July 25, 2012
July 11, 2012
June 27, 2012



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063